ISSN: 2637-4544
Brent Allan1, Jessica Whitbread2 and Mary Ann Torres3*
Received:January 11, 2019; Published: January 17, 2019
Corresponding author: Mary Ann Torres, Executive Director, International Council of AIDS Service Organizations, Canada
DOI: 10.32474/IGWHC.2019.03.000154
HIV; Community; Women; Vertical transmission
The notion that Undetectable = Untransmissible (U=U) is revolutionizing the way people living with HIV are seen and treated around the world. No longer the harbingers of disease and death, those living with HIV who take HIV anti-retroviral therapy (ART) daily as prescribed and achieve and maintain an undetectable viral load (< 50 copies/ml) have effectively no risk of sexually transmitting the virus to an HIV-negative partner [1]. The global U=U campaign has been credited with beginning to change public perception of HIV transmissibility [2]. However, sexual transmission of HIV is only one way in which HIV is transmitted and it is women living with HIV who have to shoulder the additional burden of the risk of possibly transmitting HIV to their child either pre or post nattily. And even though the basis of the rationale behind U=U was proven almost two decades ago by proving that a woman prescribed ART and is virally suppressed prior to contraception, and remains undetectable throughout their pregnancy, there is virtually no vertical transmission of HIV from a mother to her infant [3] (Figure 1).
To explore some of the questions and concerns of women living with HIV regarding the broad application of U=U to their lives, ICASO commissioned a Community Brief on U=U for women living with HIV. Launched in September 2018 at the National AIDS Conference in Australia, this brief was written by a team of women living with HIV and was guided by a global community advisory committee, also made up by women living with HIV. Together they collected stories from over 65 women living with HIV from around the world and held two community consultations at the International AIDS Conference in Amsterdam in July 2018 to refine and test the content and construction of the brief. In particular, this global brief focused upon capturing the voices of women living with HIV and contains quotes of over 20 women from every region in the world. Their voices illuminate the intensely personal experiences of pregnancy, motherhood and infant feeding as well as some of the nuances around sexuality, access, equity and gender which exist in the lives of women living with HIV. The widespread adoption of the U=U discourse has provided an important opportunity to ensure that the sexual and reproductive rights of women living with HIV are recognized in the context of U=U and importantly, the profile of the U=U message has the potential to be a catalyst for the much-needed conversations about gender inequalities and violence, women’s*1 self-determination, access to treatment, women’s* involvement in research, body autonomy and informed choice as essential aspects in the lives of women* regardless of whether or not a woman* living with HIV is virally undetectable.
Perhaps the most contentious issue arising from the brief is the absence of quality research and evidence regarding the risk of HIV transmission via breastfeeding. There is an urgent need to recognize the social, emotional, practical and cultural challenges that women experience when it comes to the pressures, they are under to breastfeed or not with differing advice provided to women around the world often associated with access to clean water to provide infant formula in preference to breastfeeding. What the women expressed throughout the construction of the brief is a disconnect between medical evidence, breastfeeding guidelines, cultural practices and public health approaches to the risks and harms in relation to breastfeeding. What is most concerning is the fact that there is a fear on the part of women* living with HIV that they will not receive all the information on breastfeeding, nor will they receive appropriate social or medical support if they express their desire to breastfeed. This is both troubling and concerning. This prevents women* living with HIV from having the information they require to make their own informed decisions and choices that may affect the future health of their children and families.
This brief concludes with four actions that were ubiquitous across the communities of women* living with HIV that require urgent attention including;
I. The right of women* living with HIV to make informed choices about their sexual and reproductive rights, including the right to the birth control options of their choice as well as access to safe and legal abortion,
II. Better research into vertical transmission in the context of U=U,
III. Supporting and respecting women* living with HIV to make informed choices and the best decisions about infant feeding options for themselves and their children
IV. Increasing, improving and guaranteeing access to the range of HIV treatments that work best for women* living with HIV around the globe.
“The U=U movement is transformative . . . so profound in its implication and impact but so simple in its concept. And women - all women everywhere - too must benefit from this concept. More than ever before, we now have within our hands the opportunity to counter both perceived and experienced stigma and really embrace the fact that when individuals know their status, link to antiretroviral therapy and become virally suppressed then life can return to normal in the fullest sense.”
1 This community brief acknowledges the diversity of women living with HIV, which includes transgender men, gender queer people and others identified female at birth. The writing team felt it was important to indicate this inclusivity in this brief by using an asterisk * where our diversity is included.
Bio chemistry
University of Texas Medical Branch, USADepartment of Criminal Justice
Liberty University, USADepartment of Psychiatry
University of Kentucky, USADepartment of Medicine
Gally International Biomedical Research & Consulting LLC, USADepartment of Urbanisation and Agricultural
Montreal university, USAOral & Maxillofacial Pathology
New York University, USAGastroenterology and Hepatology
University of Alabama, UKDepartment of Medicine
Universities of Bradford, UKOncology
Circulogene Theranostics, EnglandRadiation Chemistry
National University of Mexico, USAAnalytical Chemistry
Wentworth Institute of Technology, USAMinimally Invasive Surgery
Mercer University school of Medicine, USAPediatric Dentistry
University of Athens , GreeceThe annual scholar awards from Lupine Publishers honor a selected number Read More...